VOLITIONRX LTD — Director's Dealing 2020

Sep 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2020-09-15

Reporting Person: TERRELL JASON BRADLEY MD (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-15	Common Stock	S	19500	$3.23	Disposed	34949	Direct
2020-09-18	Common Stock	M	25000	$2.47	Acquired	59949	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-18	Warrant (Right to Buy)	$2.47	M	25000	Disposed	2020-09-18	Common Stock (25000)	Direct

Footnotes

F1: On September 18, 2020, the Reporting Person exercised a warrant to purchase 25,000 shares of Common Stock of the issuer for $2.47 per share. The warrant was set to expire pursuant to its terms on September 18, 2020.